Reversal of methylprednisolone effects in allergen-exposed female BALB/c mice
Reversal of methylprednisolone effects in allergen-exposed female BALB/c mice
A high percentage of asthma is associated with aeroallergen exposures. Glucocorticoids such as methylprednisolone represent a major method for managing chronic asthma. However, studies suggested that corticosteroid therapy might have the potential to stimulate rather than inhibit adaptive immune inflammatory reactions, raising concerns about possible adverse reactions due to excessive repeated methylprednisolone treatment. Therefore, a murine model of allergen-induced inflammation was characterized and used to investigate the effects of repeated intraperitoneal (ip) and transnasal treatments with methylprednisolone (0-20 mg/kg body weight) and cyclosporin A (20 mg/kg body weight). Sensitized BALB/c female mice were exposed daily to ovalbumin (OVA) aerosols for up to 5 d with 24-h postexposure analyses for airway responses to methacholine aerosols and inflammatory cell recoveries by bronchoalveolar lavage (BAL) and tissue collagenase dispersion. Although increased tissue neutrophils, lymphocytes, monocytes, and macrophages reached maximal levels after 2 daily OVA exposures, recoverable eosinophil numbers continued to rise over the 5-d period. Daily ip treatments with a 5-mg/kg body weight dose of methylprednisolone diminished both OVA-induced airway responses to methacholine and inflammatory-cell accumulations to levels comparable to those observed with cyclosporin A. However, treatments with higher doses of methylprednisolone reversed this anti-inflammatory effect, indicated by a return to untreated levels of OVA-induced eosinophil recovery. A similar biphasic response in eosinophil recoveries was observed using daily transnasal methylprednisolone treatments that correlated with a concomitant fall and rise in BAL interleukin-13. These results supported the hypothesis that repeated high-steroid treatments might activate rather than suppress allergen-induced immune responses.
711-724
Bassett, David
15ed4432-2ab7-43f2-8503-def46cb759d8
Hirata, Fusao
40d32587-cf0e-4bcd-a62a-8c9c1b97a6a1
Gao, Xiufeng
a5802cf9-a965-43fb-9297-98e1377e459c
Kannan, Rangaramanujam
11de80ca-3ec9-45fc-8ba4-31a30ecb667d
Kerr, Janet
7b6a779d-1d7a-41b8-924d-3049a3bdc124
Doyon-Reale, Nicole
4ab539a8-c1a7-4380-aa4a-74b3abe472c6
Wilson, Susan
21c6875d-6870-441b-ae7a-603562a646b8
Lieh-Lai, Mary
a661d205-6819-423d-af5f-aa39209507c2
2010
Bassett, David
15ed4432-2ab7-43f2-8503-def46cb759d8
Hirata, Fusao
40d32587-cf0e-4bcd-a62a-8c9c1b97a6a1
Gao, Xiufeng
a5802cf9-a965-43fb-9297-98e1377e459c
Kannan, Rangaramanujam
11de80ca-3ec9-45fc-8ba4-31a30ecb667d
Kerr, Janet
7b6a779d-1d7a-41b8-924d-3049a3bdc124
Doyon-Reale, Nicole
4ab539a8-c1a7-4380-aa4a-74b3abe472c6
Wilson, Susan
21c6875d-6870-441b-ae7a-603562a646b8
Lieh-Lai, Mary
a661d205-6819-423d-af5f-aa39209507c2
Bassett, David, Hirata, Fusao, Gao, Xiufeng, Kannan, Rangaramanujam, Kerr, Janet, Doyon-Reale, Nicole, Wilson, Susan and Lieh-Lai, Mary
(2010)
Reversal of methylprednisolone effects in allergen-exposed female BALB/c mice.
Journal of Toxicology and Environmental Health Part A, 73 (11), .
(doi:10.1080/15287391003614018).
(PMID:20391114)
Abstract
A high percentage of asthma is associated with aeroallergen exposures. Glucocorticoids such as methylprednisolone represent a major method for managing chronic asthma. However, studies suggested that corticosteroid therapy might have the potential to stimulate rather than inhibit adaptive immune inflammatory reactions, raising concerns about possible adverse reactions due to excessive repeated methylprednisolone treatment. Therefore, a murine model of allergen-induced inflammation was characterized and used to investigate the effects of repeated intraperitoneal (ip) and transnasal treatments with methylprednisolone (0-20 mg/kg body weight) and cyclosporin A (20 mg/kg body weight). Sensitized BALB/c female mice were exposed daily to ovalbumin (OVA) aerosols for up to 5 d with 24-h postexposure analyses for airway responses to methacholine aerosols and inflammatory cell recoveries by bronchoalveolar lavage (BAL) and tissue collagenase dispersion. Although increased tissue neutrophils, lymphocytes, monocytes, and macrophages reached maximal levels after 2 daily OVA exposures, recoverable eosinophil numbers continued to rise over the 5-d period. Daily ip treatments with a 5-mg/kg body weight dose of methylprednisolone diminished both OVA-induced airway responses to methacholine and inflammatory-cell accumulations to levels comparable to those observed with cyclosporin A. However, treatments with higher doses of methylprednisolone reversed this anti-inflammatory effect, indicated by a return to untreated levels of OVA-induced eosinophil recovery. A similar biphasic response in eosinophil recoveries was observed using daily transnasal methylprednisolone treatments that correlated with a concomitant fall and rise in BAL interleukin-13. These results supported the hypothesis that repeated high-steroid treatments might activate rather than suppress allergen-induced immune responses.
This record has no associated files available for download.
More information
Published date: 2010
Identifiers
Local EPrints ID: 190897
URI: http://eprints.soton.ac.uk/id/eprint/190897
ISSN: 1528-7394
PURE UUID: 908fc5df-3140-4f3e-96a2-88a982db047f
Catalogue record
Date deposited: 16 Jun 2011 09:10
Last modified: 14 Mar 2024 03:42
Export record
Altmetrics
Contributors
Author:
David Bassett
Author:
Fusao Hirata
Author:
Xiufeng Gao
Author:
Rangaramanujam Kannan
Author:
Janet Kerr
Author:
Nicole Doyon-Reale
Author:
Mary Lieh-Lai
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics